Adverse effects in a newborn infant breast-fed by a mother treated with doxepin

Annals of Pharmacotherapy

Volumn 33, Issue 6, 1999, Pages 690-693

  Frey, Otto R ^a,b   Scheidt, Peter ^c   Von Brenndorff, Alexis I ^c  

^a Hospital of Heidenheim   (Germany)

^b Kreiskrankenhaus Heidenheim   (Germany)

^c NONE

Author keywords

Breast feeding; Doxepin; Pediatrics

Indexed keywords

DOXEPIN; NORDOXEPIN;

ARTICLE; BREAST FEEDING; CASE REPORT; DEPRESSION; DROWSINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG MILK LEVEL; HUMAN; HYPERBILIRUBINEMIA; MALE; MUSCLE HYPOTONIA; NEWBORN; PHOTOTHERAPY; PRIORITY JOURNAL; SUCKING; TREATMENT OUTCOME; VOMITING;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BREAST FEEDING; DOXEPIN; FEMALE; HUMANS; INFANT, NEWBORN; MILK, HUMAN;

EID: 0032993664     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18210     Document Type: Article

References (16)

1. Pinder RM, Brogden RN, Speighl TM, Avery GS. Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression. Drugs 1977;13:161-218.
2. Fachinformation. Aponal (doxepin). Mannheim, Germany: Boehringer Mannheim GmbH, 1996:1-4.
3. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th ed. Baltimore: Williams & Wilkins, 1994:302/d-4/d.
4. Falterman CG, Richardson CJ. Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Pediatr 1980;97:308-10.
5. McBride WG. Limb deformities associated with iminodibenzyl hydrochloride (letter). Med J Aust 1972;1:497.
6. Sjoqvist F, Bergfors PG, Borga O, Lind M, Ygge H. Plasma disappearance of nortriptyline in a newborn infant following placental transfer from an intoxicated mother: evidence for drug metabolism. J Pediatr 1972;80:496-500.
7. Kemp J, Ilett KF, Booth J, Hackett LP. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985;20:497-9.
8. Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk (letter). Lancet 1985;2:1124.
9. Hackett LP, Dusci LJ, Ilett KF. A comparison of high-performance liquid chromatography and fluorescence polarization immunoassay for therapeutic drug monitoring of tricyclic antidepressants. Ther Drug Monit 1998;20:30-4.
10. Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995;28:235-69.
11. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk. Clin Pharmacokinet 1994;27:270-89.
12. Ziegler VE, Biggs JT, Wylie LT, Rosen SH, Hawi DJ. Coryell WH. Doxepin kinetics. Clin Pharmacol Ther 1978;23:573-9.
13. Warner A. Drug use in the neonate: interrelationships of pharmacokinetics, toxicity and biochemical maturity. Clin Chem 1986;32:721-7.
14. Pfeifer S. Pharmakokinetik im neugeborenen-und kindesalter. Pharmazie 1992;47:735-44.
15. Amsterdam J, Brunswick D, Mendels J. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 1980;137:653-62.
16. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996;153:1132-7.